Tetramine cupruretic agents: a comparison in dogs.
The cupruretic effects of 2 tetramine (N,N'-bis (2-aminoethyl) alkane diamine) chelators were examined in healthy dogs fed a commercial dog food containing 12.2 micrograms of copper/g of dry diet. Two groups of 3 dogs each were given either 300 mg of 2,2,2-tetramine tetrahydrochloride or 2,3,2-tetramine tetrahydrochloride for 23 consecutive days. Serum and 24-hour urine samples obtained before drug administration and during therapy were analyzed for copper, zinc, and iron concentrations. Both tetramines produced a significant cupruresis without significant changes in serum copper or in serum or urine zinc and iron concentrations. The 2,3,2-tetramine tetrahydrochloride produced a 4- to 9-fold greater cupruresis than did 2,2,2-tetramine tetrahydrochloride and resulted in a daily loss of more than 2 mg of copper in the urine. The dogs had no laboratory or clinical evidence of toxic side effects to either cupruretic agent during the treatment period. The results of the present study indicate that 2,3,2-tetramine should be an effective decoppering drug for use in dogs.
D000818:Animals; D002614:Chelating Agents / Q000494:pharmacology*; D003300:Copper / Q000097:blood / Q000378:metabolism* / Q000652:urine; D004285:Dogs / Q000378:metabolism*; D005029:Ethylenediamines / Q000494:pharmacology*; D005260:Female; D007501:Iron / Q000097:blood / Q000652:urine; D011073:Polyamines / Q000494:pharmacology*; D014266:Trientine / Q000494:pharmacology*; D015032:Zinc / Q000097:blood / Q000652:urine
D002614:Chelating Agents; D005029:Ethylenediamines; D011073:Polyamines; C022177:2,3,2-tetramine; D003300:Copper; D007501:Iron; D015032:Zinc; D014266:Trientine